FORIBUS
Foribus is a strategy management consulting firm with a focus in the use of technologies in companies.
FORIBUS
Industry:
Consulting Information Technology Management Consulting Social Media
Founded:
2013-01-01
Address:
Renton, Washington, United States
Country:
United States
Website Url:
http://www.foribus.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Font Awesome Mobile Non Scaleable Content Sectigo SSL Sectigo Domain SSL LiteSpeed ThemePunch Namecheap DNS
Similar Organizations
Highwire Ventures
Highwire is a strategy-led consulting firm & venture studio with innovation at its core.
Official Site Inspections
http://www.foribus.com
- Host name: dashroad.com
- IP address: 198.187.29.37
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "Foribus"
Forbius - Crunchbase Company Profile & Funding
Forbius (Formation Biologics) is a clinical-stage company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases. The company is developing โฆSee details»
Forbius - LinkedIn
Forbius | 2,369 followers on LinkedIn. A clinical stage company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases. | About Forbius: Targeting โฆSee details»
Forbius 2025 Company Profile: Valuation, Investors, โฆ
Forbius was founded in 2011. Where is Forbius headquartered? Forbius is headquartered in Montreal, Canada. What is the size of Forbius? Forbius has โฆSee details»
Forbius - Ownership and Business Overview - Mergr
Aug 24, 2020 Forbius was founded in 2011. Life Science M&A Summary in 2020. Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest โฆSee details»
Forbius Company Profile - Office Locations, Competitors ... - Craft
Sep 21, 2020 Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases. It provides โฆSee details»
Forbius - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Venture Round - Forbius . 4: โฆSee details»
Bristol-Myers Squibb acquires Forbius - 2020-08-24 - Crunchbase
Aug 24, 2020 Forbius Forbius is a biopharmaceutical company that develops and designs niotherapeutics for the treatment of fibrotic diseases and cancers. Acquiring Organization: โฆSee details»
Bristol Myers Squibb Completes Acquisition of Forbius
Sep 21, 2020 Adds Phase 1 Isoform-Selective TGF-beta Inhibitor AVID200 to Expansive Pipeline Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully โฆSee details»
Bristol Myers Squibb Enters Agreement to Acquire โฆ
TIAP portfolio company Forbius announced on August 24, 2020 that they have entered into an acquisition deal with Bristol Myers Squibb. BMS is adding lead TGF-beta asset to its portfolio. TIAP was one of the earliest investors and โฆSee details»
Forbius Information - RocketReach
About Forbius: Targeting EGFR and TGF-ฮฒ Pathways in Cancer and Fibrosis Forbius is a clinical stage company that designs and develops biotherapeutics for the treatment of cancer and โฆSee details»
Forbius - Overview, News & Similar companies | ZoomInfo.com
Nov 18, 2019 Forbius. Business Services · Canada · <25 Employees. View Company Info for Free. About. Headquarters 750 Boul. Saint-laurent Ste 101, Montreal, Queb... Website โฆSee details»
Forbius - Contacts, Employees, Board Members, Advisors & Alumni
Forbius is a biopharmaceutical company that develops and designs niotherapeutics for the treatment of fibrotic diseases and cancers. ... Experience the new Crunchbase, powered by AI โฆSee details»
Bristol Myers Squibb Completes Acquisition of Forbius
Sep 21, 2020 NEW YORK--(BUSINESS WIRE)--Sep 21, 2020-- Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its transaction to acquire Forbius for โฆSee details»
Bristol Myers Squibb Enters Agreement to Acquire Forbius, Adding โฆ
Aug 24, 2020 Forbiusโs Lead TGF-beta Asset, AVID200, is an Isoform-Selective TGF-beta Inhibitor, Currently in Phase 1 for Oncology and Fibrosis Bristol Myers Squibb (NYSE: BMY) โฆSee details»
Bristol Myers Squibb - osler.com
Forbius is a clinical stage protein engineering company focused on the development of biotherapeutics to treat fibrosis and cancer. Forbius has developed a portfolio of highly โฆSee details»
Forbius Agrees to Sell to Bristol Myers Squibb - Cooley
New York โ August 25, 2020 โ Cooley advised Forbius โ a clinical-stage protein engineering company that designs and develops biotherapeutics for the treatment of cancer and fibrotic โฆSee details»
Forbius - Updates, News, Events, Signals & Triggers - Crunchbase
Organization. Forbius . Connect to CRM . Save . Summary Financials People Technology Signals & News Similar Companies. Recent News & Activity. Edit Recent News & Activity Section. โฆSee details»
Bristol Myers to buy Forbius in hunt for Opdivo-enhancing drugs
Aug 24, 2020 Bristol Myers Squibb has struck a deal to buy Forbius for its portfolio of TGF-beta inhibitors. The takeover will give Bristol Myers control of a clinical-phase inhibitor of TGF-beta โฆSee details»
Forbius - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Forbius . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Total Products Active 8. Active Tech Count 1. โฆSee details»
Forbius | Work In Tech Job Board - communitech.ca
Forbius (Formation Biologics) is a clinical-stage company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases. The company is developing โฆSee details»